Disease

Cardiac Amyloidosis

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · OBSERVATIONAL STUDY

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

ClinicalTrials.gov

This is a recruiting observational registry study with no reported results; it describes a planned diagnostic imaging evaluation in amyloid disease without outcome data.

PreliminaryCardiac Amyloidosis 18F-92/AV45/TPZA/FT8, 11CPIB Amyloid

Reported

Planned enrollment500

Primary outcome measureStandardized uptake value (SUV)

Follow-up period30 days

SEP 8, 2026 · OBSERVATIONAL STUDY

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

ClinicalTrials.gov

This is an ongoing observational diagnostic imaging study with no posted results; it is designed to evaluate safety and diagnostic performance of a novel PET tracer in a small, planned cohort.

PreliminaryCardiac Amyloidosis NCT07232459 Amyloid

Reported

Planned enrollment25

Primary outcome measure 1Safety assessment from injection to 7 days…

Primary outcome measure 2[18F]FT8 organ uptake (SUV) at single PET/C…

AUG 14, 2026 · OBSERVATIONAL STUDY

Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis

ClinicalTrials.gov

This is a prospective observational registry record with no posted results; it describes planned enrollment and outcome measures for a study investigating liver and coagulation dysfunction in cardiac transthyretin amyloidosis.

PreliminaryCardiac Amyloidosis NCT07766135 Transthyretin (TTR) Amyloid Cardiomyopathy

Reported

Planned enrollment70

Study typeObservational

Follow-up duration12 months